Singapore markets closed

Singular Genomics Systems, Inc. (OMIC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4311-0.0009 (-0.21%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 32.21M
Enterprise value -66.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.88
Price/book (mrq)0.18
Enterprise value/revenue -22.82
Enterprise value/EBITDA 0.77

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3-64.08%
S&P500 52-week change 325.38%
52-week high 31.2100
52-week low 30.3100
50-day moving average 30.4773
200-day moving average 30.4699

Share statistics

Avg vol (3-month) 3117.82k
Avg vol (10-day) 3149.29k
Shares outstanding 574.07M
Implied shares outstanding 674.07M
Float 846.55M
% held by insiders 113.96%
% held by institutions 148.45%
Shares short (15 Apr 2024) 4603.25k
Short ratio (15 Apr 2024) 46.09
Short % of float (15 Apr 2024) 41.01%
Short % of shares outstanding (15 Apr 2024) 40.81%
Shares short (prior month 15 Mar 2024) 4813.51k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,338.67%

Management effectiveness

Return on assets (ttm)-21.25%
Return on equity (ttm)-43.17%

Income statement

Revenue (ttm)2.91M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)41.30%
Gross profit (ttm)N/A
EBITDA -97.39M
Net income avi to common (ttm)-94.82M
Diluted EPS (ttm)-1.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)175.4M
Total cash per share (mrq)2.37
Total debt (mrq)75.29M
Total debt/equity (mrq)42.06%
Current ratio (mrq)10.51
Book value per share (mrq)2.42

Cash flow statement

Operating cash flow (ttm)-73.65M
Levered free cash flow (ttm)-36.81M